Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

virbac, 1ère avenue 2065 m lid, 06516 carros, francuska - inaktivirana leptospira interrogans serogrupa canicola serovar canicola, soj 601903 inaktivirana leptospira interrogans serogrupa icterohaemorrhagiae serovar icterohaemorrhagiae, soj 601895 - suspenzija za injekciju - pasa

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

virbac, 1ère avenue 2065 m lid, 06516 carros, francuska - liofilizat:; virus parainfluence pasa (cpiv), soj manhattan suspenzija:; inaktivirana leptospira interrogans serogrupa canicola serovar canicola, soj 601903; inaktivirana leptospira interrogans serogrupa icterohaemorrhagiae serovar icterohaemorrhagiae, soj 601895 ; - liofilizat i suspenzija za suspenziju za injekciju - pasa

Europska Unija - hrvatski - EMA (European Medicines Agency)

amgen europe b.v. - pegfilgrastim - neutropenija - Иммуностимуляторы, - smanjenje duljine trajanja neutropenije i incidencije febrilne neutropenije u odraslih bolesnika liječenih citotoksičnom kemoterapijom zbog zloćudne bolesti (uz iznimku kronične mijeloične leukemije i mijelodisplastičnog sindroma).

Europska Unija - hrvatski - EMA (European Medicines Agency)

amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - imunosupresivi - molimo pogledajte odjeljak 4. 1 sažetak značajki proizvoda u dokumentu o informacijama o proizvodu.

Europska Unija - hrvatski - EMA (European Medicines Agency)

intervet international b.v. - svinjski circovirus tip 2 orf2 podjedinica antigena - immunologicals for suidae, inactivated viral vaccines - svinje - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection.  to reduce loss of daily weight gain and mortality associated with pcv2 infection.

Europska Unija - hrvatski - EMA (European Medicines Agency)

vbi vaccines b.v. - hepatitis b površinski antigen - hepatitis b - cjepiva - prehevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis b virus in adults. it can be expected that hepatitis d will also be prevented by immunisation with prehevbri as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection. the use of prehevbri should be in accordance with official recommendations.

Europska Unija - hrvatski - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain: a/california/7/2009 (h1n1)-derived strain used nymc x-181 - influenza, human; immunization; disease outbreaks - cjepiva protiv gripe - profilakcija influence uzrokovana virusom a (h1n1v) 2009. focetria mora se koristiti u skladu sa službenim vodstvom.

Europska Unija - hrvatski - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - imunomodulatori za mačke, - mačke - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Europska Unija - hrvatski - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - imunomodulatori za mačke, - mačke - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sanofi pasteur, 14 espace henry vallee, lyon, francuska - toksoid difterije toksoid tetanusa - suspenzija za injekciju u napunjenoj štrcaljki - 1 doza = 0,5 ml - urbroj: jedna doza od 0,5 ml sadrži: toksoid difterije*1 ne manje od 2 iu*2, toksoid tetanusa*1 ne manje od 20 iu*2 *1 adsorbiran na aluminijev hidroksid, hidratizirani (0,6 mg al3+) *2 kao donja granica pouzdanosti (p= 0,95)